Health X Platform Limited, formerly known as Sastasundar Ventures Limited, has officially executed a Tripartite Agreement with Sastasundar Healthbuddy Limited (SHBL), a material subsidiary, and Envision India Fund, a qualified institutional investor, marking a significant step in the company’s corporate restructuring and strategic investment plans. The agreement was approved by the Board of Directors at its meeting held on 27th February 2026, following SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, including Regulation 30 disclosures.

The Tripartite Agreement follows a previously executed Share Purchase Agreement (SPA) dated 25th February 2026, under which Envision India Fund acquired the entire shareholding of Mitsubishi Corporation in SHBL. The agreement outlines the merger of SHBL with Health X Platform, ensuring that the economic interest of Envision in the combined entity remains consistent with its prior investment in SHBL, subject to compliance with applicable laws.

In the event the merger cannot be consummated, the agreement provides for a share swap arrangement that guarantees Envision India Fund will receive an equivalent number of Health X Platform shares in exchange for shares held in SHBL, maintaining fairness and protecting shareholder value. Furthermore, the agreement grants Envision the right to nominate a director on the Board of Health X Platform under certain circumstances, ensuring proper oversight and governance.

The transaction qualifies as a related party transaction, as SHBL is a material subsidiary of Health X Platform, and has been structured to comply with arm’s length principles. Post-transaction, the shareholding structure is defined as: Health X Platform – 17,100,160 equity shares, Rohto Pharmaceuticals Co., Ltd. – 3,562,064 equity shares, and Envision India Fund – 10,13,766 equity shares, totaling 21,675,990 equity shares.

The Board meeting, conducted from 2:30 PM to 3:00 PM IST on 27th February 2026, reflects the company’s commitment to strategic partnerships, regulatory compliance, and transparent corporate governance. The agreement ensures that the interests of all parties, particularly Envision India Fund, are safeguarded while advancing the corporate growth strategy and operational consolidation of SHBL under Health X Platform.

This milestone is a crucial part of Health X Platform’s ongoing efforts to strengthen its material subsidiaries, optimize operational efficiency, and align shareholder interests with long-term growth. The Tripartite Agreement highlights the company’s proactive approach to mergers and acquisitions, investor relations, and governance transparency, providing clarity to shareholders and regulatory authorities.

Through this agreement, Health X Platform not only facilitates investor participation and strategic alignment but also ensures adherence to SEBI regulations, offering a structured path for the merger of SHBL, potential share swaps, and Board representation rights. This development positions Health X Platform as a robust and compliant corporate entity prepared for future growth and enhanced shareholder value in the Indian healthcare and digital health sector.

Join our Telegram Channel for Latest News and Regular Updates.

Start your Mutual Fund Journey  by Opening Free Account in Asset Plus.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.